BioMarin Reports First Quarter 2025 Results and Reaffirms Full-year Guidance
Go back to BioMarin Reports First Quarter 2025 Results and Reaffirms Full-year Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 60.26 -1.09 (1.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.35 | 52 Week High | $108.96 | |||
| Open | $61.50 | 52 Week Low | $62.12 | |||
| Day High | $61.50 | P/E | N/A | |||
| Day Low | $60.17 | EPS | $-1.27 | |||
| Volume | 1,791,426 | |||||
